Viewing Study NCT04433156


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-04-12 @ 12:58 AM
Study NCT ID: NCT04433156
Status: UNKNOWN
Last Update Posted: 2023-05-18
First Post: 2020-06-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Sponsor: Henan Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Marginal Zone Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Marginal Zone Lymphoma View
None VR-CAP View